Conserved transcriptional regulatory mechanisms in aortic valve development and disease
- PMID: 24665126
- PMCID: PMC3967128
- DOI: 10.1161/ATVBAHA.113.302071
Conserved transcriptional regulatory mechanisms in aortic valve development and disease
Abstract
There is increasing evidence for activation of developmental transcriptional regulatory pathways in heart valve disease. Here, we review molecular regulatory mechanisms involved in heart valve progenitor development, leaflet morphogenesis, and extracellular matrix organization that also are active in diseased aortic valves. These include regulators of endothelial-to-mesenchymal transitions, such as the Notch pathway effector RBPJ, and the valve progenitor markers Twist1, Msx1/2, and Sox9. Little is known of the potential reparative or pathological functions of these developmental mechanisms in adult aortic valves, but it is tempting to speculate that valve progenitor cells could contribute to repair in the context of disease. Likewise, loss of either RBPJ or Sox9 leads to aortic valve calcification in mice, supporting a potential therapeutic role in prevention of disease. During aortic valve calcification, transcriptional regulators of osteogenic development are activated in addition to valve progenitor regulatory programs. Specifically, the transcription factor Runx2 and its downstream target genes are induced in calcified valves. Runx2 and osteogenic genes also are induced with vascular calcification, but activation of valve progenitor markers and the cellular context of expression are likely to be different for valve and vascular calcification. Additional research is necessary to determine whether developmental mechanisms contribute to valve repair or whether these pathways can be harnessed for new treatments of heart valve disease.
Keywords: aortic valve stenosis; bicuspid aortic valve; extracellular matrix; fetal heart; transcription factors.
Figures
Similar articles
-
Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves.J Mol Cell Cardiol. 2011 Mar;50(3):561-9. doi: 10.1016/j.yjmcc.2010.12.005. Epub 2010 Dec 14. J Mol Cell Cardiol. 2011. PMID: 21163264 Free PMC article.
-
Interstitial cells in calcified aortic valves have reduced differentiation potential and stem cell-like properties.Sci Rep. 2019 Sep 10;9(1):12934. doi: 10.1038/s41598-019-49016-0. Sci Rep. 2019. PMID: 31506459 Free PMC article.
-
Cadherin-11 Overexpression Induces Extracellular Matrix Remodeling and Calcification in Mature Aortic Valves.Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1627-37. doi: 10.1161/ATVBAHA.116.307812. Epub 2016 Jun 16. Arterioscler Thromb Vasc Biol. 2016. PMID: 27312222 Free PMC article.
-
A Notch more: Molecular players in bicuspid aortic valve disease.J Mol Cell Cardiol. 2019 Sep;134:62-68. doi: 10.1016/j.yjmcc.2019.05.018. Epub 2019 May 28. J Mol Cell Cardiol. 2019. PMID: 31150732 Review.
-
Transcriptional regulation of heart valve development and disease.Cardiovasc Pathol. 2011 May-Jun;20(3):162-7. doi: 10.1016/j.carpath.2010.06.010. Epub 2010 Aug 11. Cardiovasc Pathol. 2011. PMID: 20705485 Free PMC article. Review.
Cited by
-
Dissecting Calcific Aortic Valve Disease-The Role, Etiology, and Drivers of Valvular Fibrosis.Front Cardiovasc Med. 2021 May 10;8:660797. doi: 10.3389/fcvm.2021.660797. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34041283 Free PMC article. Review.
-
Treatment with XAV-939 prevents in vitro calcification of human valvular interstitial cells.PLoS One. 2018 Dec 7;13(12):e0208774. doi: 10.1371/journal.pone.0208774. eCollection 2018. PLoS One. 2018. PMID: 30532256 Free PMC article.
-
Three-Dimensional Bioprinting of Ovine Aortic Valve Endothelial and Interstitial Cells for the Development of Multicellular Tissue Engineered Tissue Constructs.Bioengineering (Basel). 2023 Jun 30;10(7):787. doi: 10.3390/bioengineering10070787. Bioengineering (Basel). 2023. PMID: 37508814 Free PMC article.
-
Endothelial-to-Mesenchymal Transition in Calcific Aortic Valve Disease.Acta Cardiol Sin. 2020 May;36(3):183-194. doi: 10.6515/ACS.202005_36(3).20200213A. Acta Cardiol Sin. 2020. PMID: 32425433 Free PMC article. Review.
-
Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2387-93. doi: 10.1161/ATVBAHA.114.302523. Epub 2014 Sep 4. Arterioscler Thromb Vasc Biol. 2014. PMID: 25189570 Free PMC article. Review.
References
-
- Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation. 2006;114:e84–231. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials